Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleFocus: Antimicrobial Resistance

Topical Antiseptics in Healthcare

Michelle M Jackson
American Society for Clinical Laboratory Science July 2005, 18 (3) 160-169; DOI: https://doi.org/10.29074/ascls.18.3.160
Michelle M Jackson
is a Microbiologist at the Food and Drug Administration at Rockville, MD
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jacksonm@cder.fda.gov
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Michelle M Jackson, PhD⇑
    1. is a Microbiologist at the Food and Drug Administration at Rockville, MD
  1. Address for correspondence: Michelle M Jackson PhD, Microbiologist, Food and Drug Administration (FDA), Center for Drug Evaluation and Research, Office of Nonprescription Products, 5600 Fishers Lane, HFD-560, Rockville MD 20857. (301) 827-2284. jacksonm{at}cder.fda.gov
  1. Define transient flora and resident flora and compare the two groups in terms of ease of removal.

  2. Describe the FDA regulatory approval process for a drug product.

  3. Define the following terms: antimicrobial soap, skin antiseptic, healthcare personnel handwash, surgical hand scrub, and patient preoperative skin preparation.

  4. Identify the types of healthcare topical antiseptic currently available on the market.

  5. Identify factors that may influence the antimicrobial action of an antiseptic.

Extract

Topical antiseptics are essential for infection control. Antiseptic formulations employ a variety of mechanisms, act at various rates and persistence intervals, demonstrate various levels of toxicity, and are more or less likely to trigger resistance. The desired characteristics are considered when selecting antiseptics for hand washing, surgical scrubbing, and patient preoperative skin preparation. The selection process requires evidence of product safety and efficacy. This article explores currently available topical antimicrobial agents used in medical settings.

INTRODUCTION Topical antiseptics are antimicrobial agents that kill, inhibit, or reduce the number of microorganisms on the skin.1 The human skin is colonized by a wide variety of microorganisms that may provide a protective mechanism to the host but also serve as a source of infection. Organisms that do not cause disease are called the “usual or normal flora”. Normal flora on the skin are “transient” or “resident”. Transient flora are contracted from the environment or from other people. In most cases, these organisms are not part of the established normal flora.2 Healthcare professionals, for example, acquire microbes including methicillin-resistant Staphylococcus aureus (MRSA) during contact with patients or contaminated surfaces. Although transient organisms are easily removed from the upper layer of the skin along with dirt particles and oil, they may become part of the resident established flora of individuals. Resident flora can be persistently isolated from the hands of most people. These organisms include coagulase-negative staphylococci, Corynebacterium (diptheroids or coryneforms), Proprionibacterium, and Acinetobacter species.

Topical antiseptics are active against both resident and transient flora…

ABBREVIATIONS: CHG = chlorhexidine gluconate; FDA = Food and Drug Administration; FR = Federal Register; GRASE = generally recognized as safe and effective; MRSA = methicillin resistant Staphylococcus aureus; NDA = new drug application; OTC = over-the-counter; PCMX = chloroxylenol; RASE = recognized as safe and effective; TFM = tentative final monograph; USP = United States Pharmacopeia.

    INDEX TERMS
  • antiseptics
  • healthcare antiseptic
  • topical antiseptic
  1. Define transient flora and resident flora and compare the two groups in terms of ease of removal.

  2. Describe the FDA regulatory approval process for a drug product.

  3. Define the following terms: antimicrobial soap, skin antiseptic, healthcare personnel handwash, surgical hand scrub, and patient preoperative skin preparation.

  4. Identify the types of healthcare topical antiseptic currently available on the market.

  5. Identify factors that may influence the antimicrobial action of an antiseptic.

  • © Copyright 2005 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 18 (3)
American Society for Clinical Laboratory Science
Vol. 18, Issue 3
Summer 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Topical Antiseptics in Healthcare
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Topical Antiseptics in Healthcare
Michelle M Jackson
American Society for Clinical Laboratory Science Jul 2005, 18 (3) 160-169; DOI: 10.29074/ascls.18.3.160

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Topical Antiseptics in Healthcare
Michelle M Jackson
American Society for Clinical Laboratory Science Jul 2005, 18 (3) 160-169; DOI: 10.29074/ascls.18.3.160
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Antibiotic Resistance: A Survival Strategy
  • Antiseptic Resistance: What Do We Know and What Does It Mean?
Show more Focus: Antimicrobial Resistance

Similar Articles

Keywords

  • antiseptics
  • healthcare antiseptic
  • topical antiseptic

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire